Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Faircado boasts 4 million products from 35 partners including eBay, Rebuy, BackMarket, and Sellpy, targeting a $4.5 trillion market of circular economy. BERLIN, Nov. 23, 2022 (GLOBE NEWSWIRE) --...
-
S&P affirms Ageas’s ‘A+’ ratings with a Stable Outlook S&P Global Ratings affirmed its 'A+' long-term issuer credit rating and insurer financial strength rating on Ageas SA/NV and its rated...
-
Public Limited Company Šiaulių bankas (reg. No. 112025254, registered office address Tilžės g. 149, Šiauliai) hereby informs that on 22 November 2022, the Audit Committee of Šiaulių bankas, having...
-
On 22 November, Šiaulių Bankas and Invalda INVL signed an agreement to merge segments of their retail businesses. Following the transaction, Šiaulių Bankas Group, in addition to the financial services...
-
On 22 November 2022 Šiaulių Bankas and Invalda INVL signed an agreement on the merger of part of the retail businesses. The Management Board of Invalda INVL approved the agreement on 22 November...
-
NEW YORK, NY, Nov. 22, 2022 (GLOBE NEWSWIRE) -- UNS DIGITAL TECHNOLOGIES, a private company registered in India and Singapore, is proud to announce the launch of its UNS Token, which will help users...
-
Reported figures in U.S. Dollars Reports 34% YOY Revenue Growth Through Q3 2022 TORONTO, Nov. 22, 2022 (GLOBE NEWSWIRE) -- MiniLuxe Holding...
-
Newark, N.J., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Their nomadic lifestyle and ravenous raiding have taken army ants (Dorylinae) to most continents on Earth, but a rare fossil discovery is now offering...
-
Key Points: Long-term survival evident through 4 years in children treated with remestemcel-L in Phase 3 trial MSB-GVHD001Overall survival at 2 years was 51% in remestemcel-L treated children and...
-
Durable long-term survival outcomes through 4 years for children with steroid-refractory graft versus host disease (SR-aGVHD) treated with remestemcel-L These long-term survival outcomes are a...